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Introduction
Neurodegenerative diseases remain a poorly understood 
and growing public health concern, mired by the consistent 
failure to see advancements in therapeutic research through 
to successful clinical trials.1 The principal risk factor for the 
development of neurodegenerative disease is ageing; thus, 
it is becoming increasingly important to advance neurode-
generative research as the older population continues to 
increase. The most common neurodegenerative condition 
worldwide is Alzheimer’s disease, which presents with 
cognitive, behavioural and emotional decline, and the sec-
ond most common is Parkinson’s disease, which primarily 
affects global motor function.2
Fundamentally, these diseases bring about the loss of 
function and eventual death of neurons; however, the 
mechanisms by which this can occur are numerous and 
complex. Neurodegenerative diseases typically involve a 
series of systemic, cellular and molecular processes that can 
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be difficult to isolate and examine individually. Despite dis-
tinct clinical presentations, many of the sub-cellular aspects 
are shared between different disease types, such as protein 
misfolding and aggregation,3 and this is also true for the 
destructive mechanisms that become a steadily progressive 
and self-sustaining cycle.4 The physical degeneration that 
occurs prior to the death of neuronal cells first involves the 
loss of the connections between them; the axons and den-
drites (neurites) that help develop and maintain the vast and 
intricate communicative network of the brain. Seidel et al.5 
define this process as occurring over four distinct sequential 
phases: axonal swelling, neurite retraction, cell swelling 
with neurite degeneration and cell death.
Aspects of neurodegenerative pathology can be repli-
cated using a selective protein phosphatase 2A inhibitor, 
okadaic acid, which is commonly used to induce tau 
hyperphosphorylation in vitro.5–7 Okadaic acid is an envi-
ronmental marine toxin released by shellfish that inhibits 
protein phosphatases that are involved in a number of vital 
cellular processes. Recently, its neurotoxic effects have 
been recognised with observations of degenerating neu-
rons in vitro,8,9 and it was demonstrated to induce memory 
impairment through mitochondrial dysfunction and apop-
tosis in vivo.9,10 1-Methyl-4-phenylpyridinium (MPP+), an 
oxidative neurotoxic metabolite of 1-methyl-4-phenyl-
1,2,3,6-tetrahydropyridine (MPTP),11–13 is widely used in 
vivo and in vitro for disease modelling to induce symp-
toms of Parkinson’s disease in animal models. MPP+ has 
been found to specifically target dopaminergic neurons as 
it interferes with the oxidative phosphorylation within 
mitochondria thereby depleting ATP and causing 
apoptosis.
Three-dimensional (3D) central nervous system (CNS) 
cell culture models are a valuable research tool as they cre-
ate a physiologically relevant environment for cells allow-
ing them to behave as they would in vivo, capturing some 
of the complexity of the in vivo environment and allowing 
cellular changes to be monitored, analysed and quantified. 
They are able to recapitulate some of the mechanical cues 
provided by the extracellular matrix environment in vivo. 
In terms of neurodegeneration, 3D models can accurately 
simulate the physical degenerative processes of neurons 
and allow for degeneration to be closely assessed.14–21 
Additionally, these models can employ glial cells in co-
culture to provide a closer approximation of the in vivo 
environment.
Tissue engineering provides the opportunity for devel-
opment of artificial nervous system tissue for use in regen-
erative medicine and for in vitro modelling,17,22,23 and 
there is increased interest in the development of advanced 
tissue models that organise mixtures of neurons and glia in 
co-culture. ‘EngNT’ (engineered neural tissue) incorpo-
rates self-aligned chains of glial cells within a collagen gel 
and has been used in nervous system regenerative medi-
cine.24–28 We propose that EngNT has the potential to form 
the basis of a 3D CNS tissue model in which appropriate 
CNS cells can be incorporated. The alignment of neurites 
in EngNT facilitates quantification of neurite length and 
may provide a potentially useful platform for simulating 
neurodegeneration.
This study initially uses EngNT containing co-cultures 
of glial cells and either the neuronal cell line PC12 or 
primary rat dorsal root ganglia (DRG) neurons to create 
artificial nervous system tissue models. Additionally, the 
bioactive compound salvianolic acid B (SAB) was used as 
a treatment due to its previously reported neuroprotective 
antioxidant effects,21 to determine whether the model may 
be suitable for drug screening. Subsequently, we miniatur-
ised the model system to a scale more suited to industrial 
purposes and demonstrate how cell types more relevant for 
studying human disease such as human induced pluripo-
tent–derived stem cells can be incorporated effectively.
Materials and methods
Cell culture
Astrocytes from the rat C6 cell line (ATCC®CCL-107™) 
were maintained in culture medium (Ham’s F12; Gibco) 
supplemented with penicillin and streptomycin (100 U/mL 
and 100 mg/mL, respectively; Sigma) and 10% v/v foetal 
calf serum (Sigma) in standard cell culture flasks.
PC12 cells (rat neuronal cell line, 88022401; Sigma) 
were grown in suspension in culture medium (RPMI 1640; 
Sigma) supplemented with penicillin and streptomycin (100 
U/mL and 100 mg/mL, respectively; Sigma), 2 mM l-glu-
tamine, 10% v/v heat-inactivated horse serum and 5% v/v 
foetal calf serum (Sigma) in standard cell culture flasks.
Human induced pluripotent stem cell (iPSC)–derived 
neural progenitor cells (NPCs; ax0015; Axol) were cul-
tured on laminin-coated flasks (20 µg/mL; Millipore) and 
expanded to passage 5 with neural expansion XF-media 
(ax0030-50; Axol) supplemented with epidermal growth 
factor (EGF) and fibroblast growth factor (FGF; 20 ng/mL; 
Millipore), with a media change every 2 days.
Primary DRG neurons were dissected from adult rat 
spines. Nerve roots were stripped and DRGs were incu-
bated in 0.125% collagenase (Sigma) for 2 h at 37°C. 
Tissue was dissociated by trituration and washed twice 
by centrifugation with 10 mL of culture medium 
(Dulbecco’s Modified Eagle Medium (DMEM); Sigma) 
also supplemented with penicillin and streptomycin and 
foetal calf serum for 5 min at 250g to remove any remain-
ing collagenase.
Fabrication of EngNT co-cultures
All gels were prepared using 80% v/v Type I rat tail collagen 
(2 mg/mL in 0.6% acetic acid; First Link, UK) mixed with 
10% v/v 10× minimum essential medium (Sigma), and the 
mixture was neutralised using 5.8% v/v neutralising solu-
tion (Lonza Bioscience) before addition to 4.2% v/v cell 
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suspension (3 × 106 C6 cells/mL of gel). The collagen mix-
ture was added to various moulds as given below:
1. Rectangular mould (16 mm long) integrated with 
tethering mesh at opposite ends as described previ-
ously,20,29 which required 1 mL of collagen mixture 
and was termed ‘1-mL gel’.
2. A custom-designed scaled down (6 mm long) ver-
sion of the mould described above that requires 50 
µL of collagen mixture, 20 times less material and 
fewer cells and was termed ‘50-µL gel’
All gels were allowed to set at 37°C for 15 min. Cellular 
gels were immersed in culture medium and incubated at 
37°C in a humidified incubator with 5% CO2/95% air for 
up to 24 h, during which time the C6 cells become 
aligned.30 Using RAFT absorbers (Lonza Bioscience), the 
aligned gels were stabilised for 15 min (1-mL gel) or 3 
min (50-µL gel). Stabilisation is a process whereby a bio-
compatible material is placed upon a gel and slowly 
absorbs interstitial fluid to generate a dense robust hydro-
gel with a 50-fold increase in cell and collagen density. 
PC12 cells, iPSC or DRG neurons (75,000 per gel) were 
cultured on the surface of the stabilised collagen gel and 
maintained in culture for 3 days to allow for neurite 
growth before treatments were applied. PC12 cells were 
incubated with nerve growth factor (100 ng/mL; Sigma) 
while iPSCs were maintained in neural differentiation 
XF-media (ax0034-125; Axol) to promote neuronal 
differentiation.
Neurotoxicity
After 3 days, culture medium was removed and replaced 
with either 3 mL fresh Ham’s F12 media (control) or 3 mL 
Ham’s F12 media with added neurotoxin for 24 h, before 
fixing in 4% paraformaldehyde (PFA) at 4°C. Okadaic 
acid (Calbiochem; gift from Dr Brian Pearce, UCL) stock 
solutions were prepared in dimethyl sulfoxide (DMSO) 
and final concentrations of 5, 25 and 50 nM5 were diluted 
in cell culture medium. MPP+ (Sigma) was prepared in 
cell culture medium at concentrations of 1, 10, 30, 60 and 
100 µM.31,32 Additionally, some gels were pre-treated 
with 100 or 250 µM SAB (Sigma),33 diluted in cell culture 
medium for 30 min before addition of 30 µM MPP+ in the 
presence of SAB.
C6 toxicity
Using a 96-well plate, 240 µL of collagen solution (pre-
pared as above) containing 3 × 106 C6 cells/mL collagen 
was seeded in each well and maintained in culture medium 
and incubated for 24 h. The medium was removed, and 
gels were then stabilised using RAFT absorbers (Lonza 
Bioscience) for 15 min. Following a further 3 days of incu-
bation in the medium, gels were exposed to okadaic acid at 
concentrations of 5, 25 and 50 nM and MPP+ at concentra-
tions of 1, 10, 30, 60 and 100 µM for 24 h, prepared as 
previously stated. Cell death was assessed using propid-
ium iodide (PI; Sigma) staining in combination with 
Hoechst 33258 (1 µg/mL; Sigma). PI was added to cul-
tures at 200 µg/mL in cell culture medium and left to incu-
bate for 15 min at 37°C. The medium was then removed, 
and the cultures were rinsed in Ham’s F12 culture medium 
and then phosphate-buffered saline (PBS) before fixation. 
Gels were incubated with Hoechst 33258 in PBS for 10 
min, before three times of 5-min washes in PBS, and ana-
lysed on a fluorescence microscope (Leica DMIRB). 
Images were taken from three random areas of each gel, 
and a cell count was obtained to give a mean percentage of 
cell death.
Immunocytochemistry
Following fixation, cell permeabilisation was performed 
using 0.5% TritonX-100 (Sigma) for 30 min. Following 
three times of 5-min washes, non-specific binding was 
blocked with 5% normal goat serum (Dako, Ely, UK) in 
PBS for 30 min. After another wash step, primary antibod-
ies diluted in PBS (mouse anti-β-tubulin III IgG; 1:400 
(Sigma), rabbit anti-glial fibrillary acidic protein (GFAP); 
1:300 (Dako)) were applied to gels and incubated over-
night at 4°C. Following three times of 10-min washes, sec-
ondary antibodies (anti-mouse DyLight 488 and anti-rabbit 
DyLight 549; 1:300; Vector Laboratories) diluted in PBS 
were added for 90 min. Hoechst 33258 was also added 
into the secondary antibody dilutions for cell counting. 
Omission of primary or secondary antibody was routinely 
used as a control.
Image analysis and quantification
Confocal microscopy (Biorad confocal fitted to Olympus 
BX51 upright microscope) was used to capture images of 
neurites from five pre-determined areas of each gel using a 
20× lens and z stacks of typically 25 µm depth. The length 
of each neurite was measured using ImageJ.
Assessment of cellular alignment
Confocal microscopy was used in the assessment of cel-
lular alignment in hydrogels. For EngNT co-cultures cre-
ated with 1-mL gel, six areas were sampled from the mid 
and side regions of the gel, as described in O’Rourke 
et al.,30 using a 20× lens and z stacks of 100 µm depth typi-
cally. For those created with 50 µL gel, z stacks were set to 
sample the entire depth, and the gel was sampled using a 
tile scan method to create a 3D image of the entire gel.
Image analysis was conducted using Volocity™ 6.4 
(PerkinElmer) running automated 3D image analysis pro-
tocols to measure the angle of cell alignment.25 Volocity 
recognises glial cell processes or neurites based on 
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fluorescence intensity thresholds and approximates them 
to a straight line using the skeletal length function, allow-
ing the length (µm) and bearing (degrees) relative to the 
long axis of the gel to be quantified.34,35
Statistical analysis
Normality tests were performed on all data to determine 
which test was appropriate, and one-way analysis of vari-
ance (ANOVA) or t-tests were performed, as data followed 
a normal distribution. A one-way ANOVA was followed 
by a Dunnett’s post hoc test to compare multiple condi-
tions against the control. For all tests, *p <0.05, **p <0.01 
and ***p <0.001 were considered to be significant.
Results
Okadaic acid induces neurite degeneration of 
PC12 and DRG neurons in a dose-dependent 
manner
To investigate the effect of okadaic acid on PC12 and DRG 
neurons, EngNT co-cultures created within a 1 mL mould 
with both cell types were incubated with various concen-
trations (5, 25 and 50 nM) of okadaic acid for 24 h. A dose-
dependent decrease in neurite length was observed for 
both cell types. Confocal micrographs depicted in Figure 
1(a) illustrate the change in neurite length in response to 
the presence of okadaic acid. A significant reduction in 
comparison to the control was observed at concentrations 
of 25 and 50 nM (Figure 1(b), 1(b)).
MPP+ induces neurite degeneration of PC12 
and DRG neurons in a dose-dependent manner
Similar to okadaic acid, the effect of MPP+ was investi-
gated following incubation of EngNT co-cultures created 
within a 1-mL mould using both PC12 and DRG neurons. 
Following exposure to concentrations of 1, 10, 30, 60 and 
100 µM MPP+, a dose-dependent decrease in neurite length 
was observed for both cell types after 24 h. Confocal 
micrographs depicted in Figure 2(a) illustrate the change 
in neurite length in response to the presence of MPP+. For 
DRG neurons, all concentrations of MPP+ resulted in a sig-
nificant decrease in neurite length when compared to the 
control (Figure 2(c)), while for PC12 cells a significant 
Figure 1. Okadaic acid induces neurite degeneration in PC12 and DRG neurons. (a) Confocal micrographs of 1 mL EngNT 
cultures show progressive degeneration of PC12 and DRG neurites stained for β-III tubulin (green) after exposure to okadaic acid 
for 24 h. Scale bar = 100 µm. Dose-dependent neurite retraction was observed in both (b) PC12 and (c) DRG neurons after 24 h 
of exposure to okadaic acid. Significant differences in neurite length were seen in the presence of 25 and 50 nM okadaic acid when 
compared to controls. N = 5 gels (PC12), N = 4 gels (DRG), mean ± SEM for each condition. One-way ANOVA with Dunnett’s 
post hoc test, *p < 0.05, **p < 0.01, ***p < 0.001.
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decrease relative to control was observed for all concentra-
tions except for 1 µM (Figure 2(b)).
C6 glial cell viability is largely unaffected by 
exposure to neurotoxins
Collagen gels containing C6 glia set in a 96-well plate 
were incubated with either okadaic acid (5, 25 or 50 nM) 
or MPP+ (1, 10, 30, 60 or 100 µM) to investigate the direct 
effect of these neurotoxins on the glial cells. The presence 
of MPP+ did not appear to increase C6 cell death, with no 
significant difference seen for all concentrations tested 
compared to the control. The presence of 25 and 50 nM 
okadaic acid, however, appeared to increase C6 cell death 
by 4% and 6%, as seen in Figure 3. Importantly, average 
C6 cell death remained under 10% across all conditions.
SAB prevents MPP+-induced neurite 
degeneration in PC12 cells
Pre-treatment of 1 mL EngNT cultures for 30 min and con-
tinued presence for 24 h of SAB at concentrations of 100 
and 250 µM prevented the reduction in mean neurite length 
in PC12 cells caused by the presence of MPP+.  The 30µM 
MPP+ concentration gives a robust and consistent reduc-
tion in neurite length and so was chosen as a suitable treat-
ment for investigation of SAB action. A reduction in 
neurite length of 56% was seen in the presence of 30 µM 
MPP+, but this reduction was not observed in the presence 
of SAB treatment, suggesting a protective effect of SAB 
(Figure 4).
Development of a stable aligned high-
throughput model
Having characterised the behaviour of PC12 and DRG 
neurons in terms of aligned growth, response to neurotox-
ins and treatments, the model system was scaled down to 
fit within the well of a 96-well plate. The resulting aligned 
gels created within the 50-µL moulds had the dimensions 
of 6 × 3 mm as seen in Figure 5 (See Supplementary infor-
mation) and reduced the number of cells and amount of 
materials required per EngNT by 95% compared to a gel 
created with the rectangular stainless steel mould. A 
detailed comparison between the alignment of C6 cells in 
gels from both types of moulds was undertaken. The angle 
of deviation (the degree by which C6 processes diverge 
from the long axis) was measured, and the results revealed 
Figure 2. MPP+ induces neurite degeneration in PC12 and DRG neurons. (a) Confocal micrographs of PC12 and DRG neurite 
degeneration after exposure to MPP+ at various concentrations for 24 h within 1 mL EngNT cultures stained to detect β-III tubulin 
immunoreactivity (green). Scale bar = 100 µm. 24 h of exposure to MPP+-induced dose-dependent neurite retraction of aligned (b) 
PC12 and (c) primary DRG neurons. Gels treated with neurotoxins were compared to untreated control gels. N = 5 gels (PC12), 
N = 4 gels (DRG), mean ± SEM for each condition. One-way ANOVA with Dunnett’s post hoc test, *p < 0.05, **p < 0.01 ***p < 
0.001.
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that alignment within a 50-µL cellular collagen gel is com-
parable to that observed within a 1-mL gel (Figure 5). 
Additionally, PC12 neurons could extend neurites on the 
surface of the 50-µL gel with a mean neurite length of 200 
± 21 µm, mirroring results seen with a 1-mL gel. This con-
firms that scaling down EngNT co-cultures does not com-
promise alignment of glial cells and aligned neurite growth 
is still supported.
iPSC-derived neurons extend aligned neurites in 
EngNT and are sensitive to MPP+
The length of neurites extended by iPSC-derived neurons 
was examined with and without MPP+ to determine the 
applicability of EngNT co-culture created using a 50-µL 
C6 gel as a tool for the study of neurodegeneration, and 
whether human iPSC-derived neurons are an appropriate 
neuronal source (Figure 6). Human iPSC-derived neurons 
extended neurites on average 300 µm under control 
conditions, while in the presence of 30 µM MPP+ this was 
significantly reduced to an average of 170 µm, a 40% 
reduction in neurite length.
Discussion
There is an unmet requirement for improved in vitro models 
that more accurately simulate the physical degenerative pro-
cesses of neurons and allow degeneration to be quantified in 
a robust and reproducible manner. The aim of this study was 
to optimise a model system to study neurite retraction in 
response to neurotoxic compounds, mimicking the early 
stages of cellular degeneration. The alignment of neurites 
from PC12, primary DRG and differentiated human iPSC 
neurons in EngNT co-cultures is supported by the aligned 
C6 astrocytes within the stabilised collagen gels,24,25 and 
alignment of neurites allows accurate measurement of neur-
ite length and ease of quantification. Neuronal differentia-
tion and neurite formation are important for the development 
of a neurodegenerative-like pathology, which can be exam-
ined in this 3D model system. In vitro 3D structures give a 
suitable physical and chemical environment which can reca-
pitulate some aspects of this natural niche for neurons and 
promote physiological neuronal properties.
Figure 4. Salvianolic acid B (SAB) prevents MPP+-induced 
neurite degeneration in PC12 cells. Following 30 min pre-
treatment of 1 mL EngNT co-cultures and presence of SAB 
for 24 h, mean neurite length of gels treated with SAB was not 
significantly different from the control, while MPP+ exposure 
with no SAB was significantly different from the control. Mean 
± SEM, n = 5 gels per concentration. One-way ANOVA with 
Dunnett’s post hoc test, **p < 0.01.
Figure 3. Neurotoxins have a minimal toxic effect on C6 glia. (a) Incubation of gels containing C6 cells with 25 and 50 nM okadaic 
acid resulted in a significant increase in cell death when compared to the control. However, in all other conditions, the level of cell 
death did not differ significantly from that in control cultures. Mean ± SEM, n = 5 gels per concentration. One-way ANOVA with 
Dunnett’s post hoc test, *p < 0.05, **p < 0.01. (b) Fluorescent micrograph show nuclei staining of C6 cells (blue) and PI staining 
(red) of dead cells in the presence of 25 nM OKA. Scale bar = 100 µm.
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The results here demonstrated neurite retraction of both 
PC12 and DRG neurons in a dose-dependent manner as a 
result of exposure to okadaic acid and MPP+. These results 
are consistent with other studies that have used these com-
pounds to induce neurodegeneration. The effects on the 
inhibition of neurite growth with exposure to these toxins 
have been previously established in primary two-dimen-
sional (2D) cell cultures.36–38 The neurotoxic effects of 
okadaic acid have been recognised with observations of 
degenerating neurons in vitro,8,9 and it was demonstrated 
to induce memory impairment through mitochondrial dys-
function and apoptosis in vivo.9,10 MPP+ toxicity is widely 
used in vivo and in vitro for disease modeling.12,13 Fang 
et al. found that treatment with 10 µM MPP+ for 24 h 
caused 39% retraction in primary dopaminergic neurons in 
vitro, a trend similarly found here using DRGs in EngNT 
co-culture.39
The effect of these neurotoxins on C6 cells were assessed 
to determine whether neurite retraction was in direct 
response to the presence of the neurotoxins or in response 
to glial cell toxicity. The results showed that higher doses of 
okadaic acid were found to have some toxic effects on glial 
cells, but cell death did not exceed 10%. This confirms that 
the neurons were not co-cultured with dying glial cells, 
indicating that the neurite degeneration observed in the co-
cultures was not caused by glial cell death.
SAB (lithospermic acid40) is a bioactive component of 
the red sage plant (Salvia miltiorrhiza) that has been 
Figure 5. Development of a 50-µL gel for generation of EngNT co-cultures. (a) An example of a tile scan of an entire gel from a 
50-µL test rig with seeding density of 3 × 106 C6 cells/mL using confocal microscopy. The C6 cells within the gel were stained for 
GFAP immunoreactivity. (b) Frequency plot of the 50-µL gel and EngNT in which the angle of deviation was measured to assess 
alignment, approximately 500 angles per gel were measured. The frequency plots show the % frequency of each angle of deviation 
in tiles from the mid and side regions of the gel. (c) Confocal projections show the alignment of PC12 cells stained for β-III tubulin 
immunoreactivity (green) on the surface of scaled down EngNT co-cultures. Scale bar = 100 µm.
Figure 6. MPP+ induces neurite degeneration of iPSC-derived 
neurons. Neurite degeneration of aligned iPSC-derived neurons 
in EngNT co-cultures created using 50-µL gel was observed 
after 24 h of exposure to 30 µM MPP+. Scale bar = 100 µm. 
Mean ± SEM. Unpaired t-test, **p < 0.01.
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researched for its benefits in treating cerebrovascular dis-
eases through antioxidant mechanisms41 and also its anti-
inflammatory properties.42 SAB aids the proliferation of 
neural stem cells following stroke in rats43 and has been 
found to support myelinated nerves following spinal cord 
injury44 and to promote neuronal cell survival via exerting 
an anti-inflammatory upon microglia,45 indicating a poten-
tial neuroprotective effect of this compound. Pre-treatment 
of EngNT co-cultures for 30 min and subsequent presence 
of this compound for 24 h significantly prevented the 
degeneration of neurites exposed to 30 µM MPP+. Other 
studies have also demonstrated the protective effects of 
SAB against MPP+-induced neuronal damage.46,47 The use 
of SAB here further demonstrates its potential neuropro-
tective effects and illustrates that the model system can be 
used to test therapeutic compounds.
In this study, robust 3D CNS tissue models engineered 
by a process of glial cell self-alignment, stabilisation and 
co-culture with neurons were developed at a scale suitable 
for high-throughput screening through the development of 
a 50-µL gel. Characterisation studies that assessed align-
ment and stabilisation of 50-µL cellular gels created within 
a 6 × 3 mm mould suggest that a highly organised, stable 
hydrogel can be created at these dimensions. Interestingly, 
the dimensions of the 50-µL gel were based on those of a 
well within a 96-well plate, highlighting that this system 
could be created in multi-well format.
The potential of EngNT co-cultures created using 50-µL 
gels for the study of neurodegeneration was confirmed 
through neurite growth from PC12 cells and iPSC-derived 
neurons. The results demonstrate that PC12 cells can 
extend neurites in EngNT co-cultures created using 50-µL 
gels, as can iPSCs. The response of human iPSC-derived 
neurons to MPP+ was assessed, and these cells demon-
strated a significant reduction in neurite length following 
exposure to MPP+ when compared to the control, indicat-
ing their suitability for use in studies investigating neuro-
degeneration. Use of human iPSC-derived neurons in this 
system creates a physiologically relevant model for study-
ing degenerative conditions. For example, EngNT co-cultures 
could perhaps incorporate iPSC-derived neurons from 
patients with neurodegenerative disease, or from specific 
individuals for stratification or personalised medicine 
strategies. However, it is important to note that the func-
tional maturation of human iPSC-derived neurons still 
remains poorly understood, which may limit the useful-
ness of these cells in modelling adult conditions.
Conclusion
Recreating key aspects of the 3D environment of the CNS 
using hydrogel matrices allows neurons and glial cells in 
vitro to behave similarly to their counterparts in vivo, provid-
ing a relevant tool for neurobiological studies. A viable 
method has been established for the production of engineered 
tissue, involving cellular self-alignment and subsequent 
stabilisation in a relatively quick and simple manner to 
examine neuronal degeneration. The aligned nature of the 
cells and extracellular matrix in this model system facilitates 
quantitative analysis of CNS cellular features such as neurite 
length and degeneration. This simple, consistent and physi-
ologically relevant model system, which uses a multi-well 
plate format, could potentially be used at a scale suitable for 
commercial R&D.
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